美年健康
(002044)
| 流通市值：228.58亿 | | | 总市值：230.94亿 |
| 流通股本：38.74亿 | | | 总股本：39.14亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,583,788,046.28 | 10,359,530,671.3 | 6,925,390,135.63 | 4,109,252,112.57 |
| 营业收入 | 1,583,788,046.28 | 10,359,530,671.3 | 6,925,390,135.63 | 4,109,252,112.57 |
| 二、营业总成本 | 1,886,216,163.78 | 9,639,113,427.74 | 6,747,899,733.5 | 4,328,231,130.4 |
| 营业成本 | 1,177,669,060.87 | 6,074,908,557.69 | 4,270,857,332.19 | 2,751,824,853.47 |
| 税金及附加 | 1,178,983.76 | 8,189,315.54 | 4,083,846.66 | 3,114,393.34 |
| 销售费用 | 420,758,331.19 | 2,341,119,289.1 | 1,573,220,297.44 | 981,957,528.93 |
| 管理费用 | 205,610,714.26 | 860,133,225.44 | 633,221,283.2 | 414,756,912.62 |
| 研发费用 | 12,087,359.76 | 52,689,620.06 | 36,848,699.31 | 24,391,424.56 |
| 财务费用 | 68,911,713.94 | 302,073,419.91 | 229,668,274.7 | 152,186,017.48 |
| 其中:利息费用 | 69,747,764.83 | 304,384,192.87 | 232,089,210.08 | 154,026,447.32 |
| 其中:利息收入 | 2,183,243.29 | 10,859,299.51 | 8,320,533.46 | 6,528,209.29 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -5,170,691.57 | 25,429,541.8 | 32,496,984.97 | 5,834,933.43 |
| 加:投资收益 | -4,988,338.94 | 35,132,537.76 | 634,287.97 | -8,415,768.74 |
| 资产处置收益 | -834,227.98 | -10,204,107.92 | -8,508,996.83 | -3,131,248.98 |
| 资产减值损失(新) | - | -60,051,831.96 | - | - |
| 信用减值损失(新) | 13,104,229.4 | -139,154,669.58 | -55,427,748.88 | -19,094,924.46 |
| 其他收益 | 5,484,840.24 | 26,254,814.19 | 17,231,945.9 | 11,008,607.07 |
| 四、营业利润 | -294,832,306.35 | 597,823,527.85 | 163,916,875.26 | -232,777,419.51 |
| 加:营业外收入 | 7,279,831.45 | 21,931,267.19 | 4,626,884.09 | 3,669,641.3 |
| 减:营业外支出 | 12,574,622.7 | 62,303,948.31 | 30,216,263.55 | 18,918,273.2 |
| 五、利润总额 | -300,127,097.6 | 557,450,846.73 | 138,327,495.8 | -248,026,051.41 |
| 减:所得税费用 | -31,322,392.9 | 186,866,034.63 | 46,867,380.06 | -25,416,251.69 |
| 六、净利润 | -268,804,704.7 | 370,584,812.1 | 91,460,115.74 | -222,609,799.72 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -268,804,704.7 | 370,584,812.1 | 91,460,115.74 | -222,609,799.72 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -255,039,233.23 | 285,327,021.07 | 51,859,853.32 | -221,363,086.13 |
| 少数股东损益 | -13,765,471.47 | 85,257,791.03 | 39,600,262.42 | -1,246,713.59 |
| 扣除非经常损益后的净利润 | -259,887,341.08 | 258,287,037.01 | 12,228,899.05 | -238,330,324.71 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.07 | 0.07 | 0.01 | -0.06 |
| (二)稀释每股收益 | -0.07 | 0.07 | 0.01 | -0.06 |
| 八、其他综合收益 | -120,928.37 | -227,114.9 | -116,396.64 | -48,028.29 |
| 归属于母公司股东的其他综合收益 | 29,063.05 | -48,223.32 | -17,533.88 | 40,630.94 |
| 九、综合收益总额 | -268,925,633.07 | 370,357,697.2 | 91,343,719.1 | -222,657,828.01 |
| 归属于母公司股东的综合收益总额 | -255,010,170.18 | 285,278,797.75 | 51,842,319.44 | -221,322,455.19 |
| 归属于少数股东的综合收益总额 | -13,915,462.89 | 85,078,899.45 | 39,501,399.66 | -1,335,372.82 |
| 公告日期 | 2026-04-30 | 2026-04-28 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |